Moderna, Inc. - COMMON STOCK (MRNA)

Historical Holders from Q4 2018 to Q4 2025

Type / Class: Equity / COMMON STOCK
Symbol: MRNA on Nasdaq
Shares outstanding: 384,509,293
Price per share: $29.49
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 274,565,676
Total reported value: $7,091,242,614
% of total 13F portfolios: 0%
Share change: -16,972,596
Value change: -$451,873,574
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 625
Price from insider filings: $30.86

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Moderna, Inc. - COMMON STOCK (MRNA) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BAILLIE GIFFORD & CO	6.5%	-36%	$665,378,042	-$371,806,817	24,948,558	-36%	BAILLIE GIFFORD & CO	31 Mar 2025
FMR LLC	3.2%	-38%	$317,820,001	-$227,968,658	12,304,297	-42%	FMR LLC	30 Sep 2025

As of 30 Sep 2025, Moderna, Inc. - COMMON STOCK (MRNA) has 625 institutional shareholders filing 13F forms. They hold 274,565,676 shares. of 384,509,293 outstanding shares (71%) .

Top 25 institutional shareholders own 56% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	11%	41,185,295	-1.3%	0.02%	$1,063,816,169
BlackRock, Inc.	7.7%	29,527,917	+3.2%	0.01%	$762,706,089
BAILLIE GIFFORD & CO	5.7%	21,846,666	-1.1%	0.42%	$564,299,382
STATE STREET CORP	4.4%	17,108,595	-0.94%	0.02%	$441,915,009
FMR LLC	3.2%	12,304,297	-37%	0.02%	$317,820,001
MORGAN STANLEY	2.6%	9,962,232	+23%	0.02%	$257,324,501
GEODE CAPITAL MANAGEMENT, LLC	2.4%	9,249,352	+4.2%	0.02%	$238,477,440
Invesco Ltd.	2.1%	8,216,163	+16%	0.03%	$212,223,494
Theleme Partners LLP	2.1%	8,068,810	+2.5%	13%	$208,417,362
TWO SIGMA INVESTMENTS, LP	2%	7,529,981	+8.2%	0.3%	$194,499,409
TWO SIGMA ADVISERS, LP	1.8%	6,772,900	-13%	0.35%	$174,944,007
D. E. Shaw & Co., Inc.	1.6%	6,146,374	-18%	0.13%	$158,760,840
UBS Group AG	1.2%	4,801,547	+22%	0.02%	$124,023,958
Flagship Pioneering Inc.	1.2%	4,632,149	0%	41%	$119,648,409
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.1%	4,312,432	+42%	0.02%	$111,390,108
GOLDMAN SACHS GROUP INC	0.83%	3,179,749	-6.6%	0.01%	$82,132,928
BANQUE PICTET & CIE SA	0.81%	3,130,724	-0.07%	0.81%	$80,866,601
NORTHERN TRUST CORP	0.76%	2,905,509	-6%	0.01%	$75,049,297
FEDERATED HERMES, INC.	0.72%	2,779,001	-3.1%	0.13%	$71,781,595
NATIONAL BANK OF CANADA /FI/	0.7%	2,704,838	+357%	0.08%	$69,865,933
Merck & Co., Inc.	0.6%	2,308,190	0%	26%	$59,620,548
CITIGROUP INC	0.54%	2,082,040	-15%	0.04%	$53,779,093
BARCLAYS PLC	0.52%	2,015,828	-7.8%	0.02%	$52,068,838
CITADEL ADVISORS LLC	0.52%	1,987,731	+8.3%	0.04%	$51,343,091
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	0.51%	1,960,968	-35%	0.01%	$50,651,803

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	427,000	$12,682,098	-$702,046			2,949%	21
2025 Q3	274,565,676	$7,091,242,614	-$451,873,574	$1,128,519,908	$1,035,847,251	2,583%	625
2025 Q2	291,423,621	$8,041,462,409	+$359,301,170	$953,917,304	$778,127,109	2,759%	663
2025 Q1	278,660,879	$7,898,813,961	-$59,278,599	$879,746,945	$673,661,963	2,835%	675
2024 Q4	276,513,445	$11,496,358,711	+$498,242,513	$1,001,589,736	$786,508,119	4,158%	721
2024 Q3	256,693,845	$17,141,220,718	-$821,160,341	$1,243,213,357	$701,421,710	6,683%	765
2024 Q2	261,770,303	$31,081,249,299	+$415,637,131	$1,431,835,450	$1,094,475,375	11,875%	937
2024 Q1	258,746,579	$27,572,294,314	+$210,315,080	$993,434,696	$1,287,010,556	10,656%	890
2023 Q4	926,644	$92,115,900	+$8,554,575	$0		9,945%	21
2023 Q3	242,676,771	$25,061,422,492	-$390,763,989	$1,093,893,433	$1,316,136,504	10,329%	850
2023 Q2	243,717,634	$29,616,698,086	-$850,131,391	$1,008,535,323	$874,382,469	12,150%	926
2023 Q1	244,653,027	$37,553,441,457	+$87,560,567	$1,358,217,998	$1,574,606,358	15,358%	976
2022 Q4	247,606,486	$44,485,667,507	+$356,823,396	$2,336,777,593	$2,479,437,255	17,962%	1,029
2022 Q3	242,017,398	$28,625,052,537	+$336,679,287	$1,254,440,475	$1,052,447,869	11,825%	857
2022 Q2	244,010,599	$34,836,190,373	-$409,618,342	$1,486,178,310	$1,275,179,410	14,285.04%	940
2022 Q1	244,747,054	$42,165,719,834	+$557,447,518	$2,950,839,880	$2,496,719,042	17,226%	963
2021 Q4	240,528,848	$61,046,373,227	+$682,705,458	$6,081,650,532	$4,126,847,799	25,397.93%	1,062
2021 Q3	242,703,410	$93,377,691,246	+$6,739,591,856	$8,314,136,062	$7,111,142,532	38,485.9%	1,113
2021 Q2	207,777,695	$48,813,776,485	+$5,169,599,408	$4,040,703,856	$3,452,747,784	23,497.96%	866
2021 Q1	188,669,379	$24,691,522,039	+$2,711,203,836	$2,083,228,560	$1,795,924,930	13,095%	753
2020 Q4	168,124,574	$17,562,895,549	-$522,664,847	$1,683,081,948	$1,236,837,683	10,447%	672
2020 Q3	204,615,301	$14,470,118,235	-$1,021,479,918	$707,544,000	$572,107,423	7,074.97%	526
2020 Q2	217,433,217	$13,955,557,692	+$1,639,150,845	$355,742,000	$414,563,000	6,421%	469
2020 Q1	190,036,694	$5,692,045,262	+$497,302,583	$54,867,000	$94,208,000	2,995.01%	274
2019 Q4	169,301,323	$3,311,146,090	+$261,075,361	$5,709,000	$16,926,000	1,956%	152
2019 Q3	105,273,717	$1,675,885,941	+$424,972,286	$5,800,000	$15,038,000	1,592%	129
2019 Q2	143,250,296	$2,096,223,867	+$128,885,901	$5,655,000	$15,100,000	1,463.98%	125
2019 Q1	138,222,036	$2,798,744,442	+$99,819,208	$5,809,000	$5,868,000	2,034.97%	101
2018 Q4	133,583,425	$2,019,179,000	+$2,019,010,863			1,527%	74